Delivering pharmaceutical care in the Netherlands: Practice and challenges

Pharmaceutical Journal

Volumn 273, Issue 7326, 2004, Pages 757-759

  Boysen, Meindert ^a  

^a NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ARTICLE; CLINICAL PRACTICE; COOPERATION; DRUG UTILIZATION; GENERAL PRACTITIONER; GOOD CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; MEDICAL INFORMATION SYSTEM; MEDICAL SPECIALIST; NETHERLANDS; PATIENT CARE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY CONTROL; QUALITY OF LIFE; RESPONSIBILITY;

EID: 10044239122     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. International Pharmaceutical Federation. FIP Statement of Professional Standards. Pharmaceutical Care. The Hague: FIP; 1998.
2. Van Mil F. Pharmaceutical care: towards an international understanding? The Pharmaceutical Journal 1999;263:464.
3. WINAp. Verantwoorde farmaceutische patientenzorg [Responsible pharmaceutical patient care]. March 2004.
4. Dutch Institute for Efficient Provision of Medicines. Wat is FTTO [What is FTTO]? Utrecht: Dutch Institute for Responsible Use of Medicines; 2001.
5. Foundation for Pharmaceutical Statistics. Data and figures 2003. The Hague: SFK; 2003.
6. Royal Dutch Pharmaceutical Society. Nederlandse Apotheeknorm: norm voor de farmaceutische zorgverlening door de openbare apotheek [Netherlands Dispensing Chemists Standards: standards for the provision of pharmaceutical care by the community pharmacy]. The Hague: Royal Dutch Association for the Advancement of Pharmacy; 1996.
7. Inspectie voor de Gezondheidszorg. Voorwaarden voor verantwoorde farmaceutische zorgverlening door openbare apotheken onderzocht [Preconditions for responsible pharmaceutical care evaluated]. The Hague:Inspectie voor de Gezondheidszorg; 2003.
8. Van Aalst A, Van Oijen A, Stroo M, De Groot J. Quick scan levert snel overzicht van overlegkwaliteit [Quickscan delivers a speedy overview in the quality of deliberations]. Pharmaceutisch Weekblad 2003;138:1738-40.
9. Biesaart M. KNMG kritisch over wetsvoorstel [Royal Dutch Medical Association is critical about proposal for bill]. Medisch Contact 2002;57:1881.
10. Demoulin LHHM, Goselink M, Van Zijp C. Prijsvorming in gezondheidszorg kan gezonder [Pricing in health care can be more healthy]. Pharmaceutisch Weekblad 2003;138:999-1003.
11. Van den Berg WAM. Niet op deze manier! [Not in this way!] comment on "Poliklinische geneesmiddelen en DBCs" [Polyclinical drugs and DBCs]. Pharmaceutisch Weekblad 2003;138:1039.
12. KNMP. Commentary of the executive committee on deleting of Article 19 - Supply of Medicines Act. The Hague: Royal Dutch Association for the Advancement of Pharmacy; 2002.
13. Inspectie voor de Gezondheidszorg. Beleid bij substitutieproblemen. Inspectie houdt vast aan farmacotherapeutische benadering [Policy with substitution problems. Inspection holds on to pharmacotherapeutic approach]. Pharmaceutisch Weekblad 2003;138:1806-7.
14. Tent M. FTO-afspraken zijn toestemming vooraf voor substitutie [FTO-agreements are consent in advance for substitution]. Pharmaceutisch Weekblad 2003;138:1805.
15. KNMG. Apotheker handelt onjuist bij eigenmachtig afwijken van recept arts [Pharmacists are acting improper when they divert from the prescription of the doctor]. Utrecht: Royal Dutch Association for the Advancement of Medicine; 2003.
16. Herings R. Geneesmiddelenonderzoek in, van en voor de zorg. PHARMO Instituut koppelt in het belang van de patient [Pharmaceutical research in, of and for health care. PHARMO Institute links (databases) to the advancement of patients]. Pharmaceutisch Weekblad 2003;138:1742-5.
17. HJM Beijer, CJ de Blaey. Betere medicatiebegeleiding bespaart ziektelast én geld [Beter medication guidance saves burden of disease and money]. Pharmaceutisch Weekblad 2002;137:609-12.